✨ Your Portfolio is fetched and updated from zerodha.
Nano
Market Cap
₹160 Cr.
P/E
401.55

Key Ratios

Market cap
Market cap
160 Cr
PE
PE
401
Prom Holding
Prom Holding
26.32 %
ROE (%)
ROE (%)
1.68
ROCE (%)
ROCE (%)
6.84
Div Yield (%)
Div Yield (%)
-
Sales
Sales
104 Cr
OPM (%)
OPM (%)
-0.85 %
Debt to Equity
Debt to Equity
0.35
About
Vaishali Pharma Limited is a company primarily engaged in marketing pharmaceutical products, i… Read more
Low
12
52W Range
High
20
  • Vaishali Pharma
  • Coral Laboratories
  • Quest Laboratories

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Vaishali Pharma Ltd. Business

Vaishali Pharma Limited is a Mumbai-based pharmaceutical company that markets a range of products, including active pharmaceutical ingredients. It has expanded its operations to international markets like Vietnam.

Vaishali Pharma major competitors are Coral Laboratories, Quest Laboratories, Krebs Biochem.&Inds, Sotac Pharmaceutical, Aarey Drugs & Pharma, IndoAmerican Advance, Parnax Lab.
Market Cap of Vaishali Pharma is ₹159 Crs.
While the median market cap of its peers are ₹163 Crs.

Vaishali Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation Mar Jun
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material